Literature DB >> 20797623

STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer.

Dimitrios Iliopoulos1, Savina A Jaeger, Heather A Hirsch, Martha L Bulyk, Kevin Struhl.   

Abstract

A transient inflammatory signal can initiate an epigenetic switch from nontransformed to cancer cells via a positive feedback loop involving NF-kappaB, Lin28, let-7, and IL-6. We identify differentially regulated microRNAs important for this switch and putative transcription factor binding sites in their promoters. STAT3, a transcription factor activated by IL-6, directly activates miR-21 and miR-181b-1. Remarkably, transient expression of either microRNA induces the epigenetic switch. MiR-21 and miR-181b-1, respectively, inhibit PTEN and CYLD tumor suppressors, leading to increased NF-kappaB activity required to maintain the transformed state. These STAT3-mediated regulatory circuits are required for the transformed state in diverse cell lines and tumor growth in xenografts, and their transcriptional signatures are observed in colon adenocarcinomas. Thus, STAT3 is not only a downstream target of IL-6 but, with miR-21, miR-181b-1, PTEN, and CYLD, is part of the positive feedback loop that underlies the epigenetic switch that links inflammation to cancer. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20797623      PMCID: PMC2929389          DOI: 10.1016/j.molcel.2010.07.023

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  36 in total

1.  An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation.

Authors:  Dimitrios Iliopoulos; Heather A Hirsch; Kevin Struhl
Journal:  Cell       Date:  2009-10-29       Impact factor: 41.582

2.  Stat3 as an oncogene.

Authors:  J F Bromberg; M H Wrzeszczynska; G Devgan; Y Zhao; R G Pestell; C Albanese; J E Darnell
Journal:  Cell       Date:  1999-08-06       Impact factor: 41.582

3.  A transcriptional signature and common gene networks link cancer with lipid metabolism and diverse human diseases.

Authors:  Heather A Hirsch; Dimitrios Iliopoulos; Amita Joshi; Yong Zhang; Savina A Jaeger; Martha Bulyk; Philip N Tsichlis; X Shirley Liu; Kevin Struhl
Journal:  Cancer Cell       Date:  2010-04-13       Impact factor: 31.743

4.  Identification of a microRNA signature associated with progression of leukoplakia to oral carcinoma.

Authors:  Nilva K Cervigne; Patricia P Reis; Jerry Machado; Bekim Sadikovic; Grace Bradley; Natalie Naranjo Galloni; Melania Pintilie; Igor Jurisica; Bayardo Perez-Ordonez; Ralph Gilbert; Patrick Gullane; Jonathan Irish; Suzanne Kamel-Reid
Journal:  Hum Mol Genet       Date:  2009-09-23       Impact factor: 6.150

5.  Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB.

Authors:  Thijn R Brummelkamp; Sebastian M B Nijman; Annette M G Dirac; René Bernards
Journal:  Nature       Date:  2003-08-14       Impact factor: 49.962

6.  CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members.

Authors:  Eirini Trompouki; Eudoxia Hatzivassiliou; Theodore Tsichritzis; Hannah Farmer; Alan Ashworth; George Mosialos
Journal:  Nature       Date:  2003-08-14       Impact factor: 49.962

7.  MicroRNA miR-210 modulates cellular response to hypoxia through the MYC antagonist MNT.

Authors:  Zhan Zhang; Hong Sun; Hongyue Dai; Ryan M Walsh; Maki Imakura; Janell Schelter; Julja Burchard; Xudong Dai; Aaron N Chang; Robert L Diaz; Joseph R Marszalek; Steven R Bartz; Michael Carleton; Michele A Cleary; Peter S Linsley; Carla Grandori
Journal:  Cell Cycle       Date:  2009-09-29       Impact factor: 4.534

Review 8.  STATs in cancer inflammation and immunity: a leading role for STAT3.

Authors:  Hua Yu; Drew Pardoll; Richard Jove
Journal:  Nat Rev Cancer       Date:  2009-11       Impact factor: 60.716

9.  Lin28 recruits the TUTase Zcchc11 to inhibit let-7 maturation in mouse embryonic stem cells.

Authors:  John P Hagan; Elena Piskounova; Richard I Gregory
Journal:  Nat Struct Mol Biol       Date:  2009-08-27       Impact factor: 15.369

10.  Myc-regulated microRNAs attenuate embryonic stem cell differentiation.

Authors:  Chin-Hsing Lin; Aimee L Jackson; Jie Guo; Peter S Linsley; Robert N Eisenman
Journal:  EMBO J       Date:  2009-09-10       Impact factor: 11.598

View more
  401 in total

Review 1.  Role of G protein-coupled receptors-microRNA interactions in gastrointestinal pathophysiology.

Authors:  Ivy Ka Man Law; David Miguel Padua; Dimitrios Iliopoulos; Charalabos Pothoulakis
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-08-03       Impact factor: 4.052

2.  MicroRNA-21 inhibits platelet-derived growth factor-induced human aortic vascular smooth muscle cell proliferation and migration through targeting activator protein-1.

Authors:  Yumei Li; Limei Yan; Wenyu Zhang; Nan Hu; Wei Chen; Hui Wang; Min Kang; Hesheng Ou
Journal:  Am J Transl Res       Date:  2014-10-11       Impact factor: 4.060

3.  Up-regulation of a HOXA-PBX3 homeobox-gene signature following down-regulation of miR-181 is associated with adverse prognosis in patients with cytogenetically abnormal AML.

Authors:  Zejuan Li; Hao Huang; Yuanyuan Li; Xi Jiang; Ping Chen; Stephen Arnovitz; Michael D Radmacher; Kati Maharry; Abdel Elkahloun; Xinan Yang; Chunjiang He; Miao He; Zhiyu Zhang; Konstanze Dohner; Mary Beth Neilly; Colles Price; Yves A Lussier; Yanming Zhang; Richard A Larson; Michelle M Le Beau; Michael A Caligiuri; Lars Bullinger; Peter J M Valk; Ruud Delwel; Bob Lowenberg; Paul P Liu; Guido Marcucci; Clara D Bloomfield; Janet D Rowley; Jianjun Chen
Journal:  Blood       Date:  2012-01-17       Impact factor: 22.113

4.  A comprehensive view of nuclear receptor cancer cistromes.

Authors:  Qianzi Tang; Yiwen Chen; Clifford Meyer; Tim Geistlinger; Mathieu Lupien; Qian Wang; Tao Liu; Yong Zhang; Myles Brown; Xiaole Shirley Liu
Journal:  Cancer Res       Date:  2011-09-22       Impact factor: 12.701

5.  Tumorigenesis: Dangerous micromanagement.

Authors:  Darren J Burgess
Journal:  Nat Rev Cancer       Date:  2010-10       Impact factor: 60.716

6.  Enforced expression of Lin28b leads to impaired T-cell development, release of inflammatory cytokines, and peripheral T-cell lymphoma.

Authors:  Sarah H Beachy; Masahiro Onozawa; Yang Jo Chung; Chris Slape; Sven Bilke; Princy Francis; Marbin Pineda; Robert L Walker; Paul Meltzer; Peter D Aplan
Journal:  Blood       Date:  2012-06-21       Impact factor: 22.113

Review 7.  Overview upon miR-21 in lung cancer: focus on NSCLC.

Authors:  Cecilia Bica-Pop; Roxana Cojocneanu-Petric; Lorand Magdo; Lajos Raduly; Diana Gulei; Ioana Berindan-Neagoe
Journal:  Cell Mol Life Sci       Date:  2018-07-20       Impact factor: 9.261

8.  Epigenetic changes associated with inflammation in breast cancer patients treated with chemotherapy.

Authors:  Alicia K Smith; Karen N Conneely; Thaddeus W W Pace; Donna Mister; Jennifer C Felger; Varun Kilaru; Mary J Akel; Paula M Vertino; Andrew H Miller; Mylin A Torres
Journal:  Brain Behav Immun       Date:  2014-02-28       Impact factor: 7.217

9.  An integrated transcriptional regulatory circuit that reinforces the breast cancer stem cell state.

Authors:  Christos Polytarchou; Dimitrios Iliopoulos; Kevin Struhl
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-20       Impact factor: 11.205

10.  Identification of microRNA-181a-5p and microRNA-4454 as mediators of facet cartilage degeneration.

Authors:  Akihiro Nakamura; Y Raja Rampersaud; Anirudh Sharma; Stephen J Lewis; Brian Wu; Poulami Datta; Kala Sundararajan; Helal Endisha; Evgeny Rossomacha; Jason S Rockel; Igor Jurisica; Mohit Kapoor
Journal:  JCI Insight       Date:  2016-08-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.